Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-23 3:51 pm Purchase | 2024-12-19 | 13D | Aadi Bioscience, Inc. AADI | AVORO CAPITAL ADVISORS LLC | 3,581,961 14.500% | 110,209 (+3.17%) | Filing History |
| 2024-11-14 09:40 am Purchase | 2024-09-30 | 13G | Taysha Gene Therapies, Inc. TSHA | AVORO CAPITAL ADVISORS LLC | 23,094,444 9.990% | 23,094,444 (New Position) | Filing History |
| 2024-11-14 09:39 am Purchase | 2024-09-30 | 13G | Tourmaline Bio, Inc. TRML | AVORO CAPITAL ADVISORS LLC | 2,222,222 8.700% | 2,222,222 (New Position) | Filing History |
| 2024-11-14 09:39 am Purchase | 2024-09-30 | 13G | Avidity Biosciences, Inc. RNA | AVORO CAPITAL ADVISORS LLC | 9,935,792 8.300% | 9,935,792 (New Position) | Filing History |
| 2024-11-14 09:38 am Purchase | 2024-09-30 | 13G | Arrowhead Pharmaceuticals, Inc. ARWR | AVORO CAPITAL ADVISORS LLC | 8,888,888 7.200% | 8,888,888 (New Position) | Filing History |
| 2024-11-14 09:37 am Purchase | 2024-09-30 | 13G | Ocular Therapeutix, Inc. OCUL | AVORO CAPITAL ADVISORS LLC | 12,714,874 7.900% | 12,714,874 (New Position) | Filing History |
| 2024-11-14 09:36 am Purchase | 2024-09-30 | 13G | Soleno Therapeutics, Inc. SLNO | AVORO CAPITAL ADVISORS LLC | 2,181,000 5.600% | 2,181,000 (New Position) | Filing History |
| 2024-11-14 09:35 am Purchase | 2024-09-30 | 13G | Vera Therapeutics, Inc. VERA | AVORO CAPITAL ADVISORS LLC | 4,309,590 7.900% | 4,309,590 (New Position) | Filing History |
| 2024-11-14 09:35 am Sale | 2024-09-30 | 13G | Spyre Therapeutics, Inc. SYRE | AVORO CAPITAL ADVISORS LLC | 885,059 1.700% | -954,079 (-51.88%) | Filing History |
| 2024-11-14 09:34 am Sale | 2024-09-30 | 13G | Marinus Pharmaceuticals, Inc. MRNS | AVORO CAPITAL ADVISORS LLC | 0 0.000% | -3,150,000 (Position Closed) | Filing History |
| 2024-11-14 09:33 am Sale | 2024-09-30 | 13G | Structure Therapeutics Inc. GPCR | AVORO CAPITAL ADVISORS LLC | 0 0.000% | -6,999,999 (Position Closed) | Filing History |
| 2024-11-14 09:32 am Sale | 2024-09-30 | 13G | Verrica Pharmaceuticals Inc. VRCA | AVORO CAPITAL ADVISORS LLC | 0 0.000% | -6,583,332 (Position Closed) | Filing History |
| 2024-11-14 09:31 am Sale | 2024-09-30 | 13G | Amicus Therapeutics, Inc. FOLD | AVORO CAPITAL ADVISORS LLC | 23,175,000 7.800% | -4,225,000 (-15.42%) | Filing History |
| 2024-11-14 09:31 am Purchase | 2024-09-30 | 13G | Ascendis Pharma A/S ASND | AVORO CAPITAL ADVISORS LLC | 4,988,888 8.200% | 1,233,333 (+32.84%) | Filing History |
| 2024-11-14 09:30 am Purchase | 2024-09-30 | 13G | Kymera Therapeutics, Inc. KYMR | AVORO CAPITAL ADVISORS LLC | 7,750,000 9.990% | 3,975,000 (+105.30%) | Filing History |
| 2024-04-23 6:22 pm Sale | 2023-12-31 | 13G | Spyre Therapeutics, Inc. SYRE | AVORO CAPITAL ADVISORS LLC | 1,839,138 5.100% | -286,459 (-13.48%) | Filing History |
| 2024-02-14 09:25 am Purchase | 2023-12-31 | 13G | Krystal Biotech, Inc. KRYS | AVORO CAPITAL ADVISORS LLC | 2,565,555 9.100% | 1,155,555 (+81.95%) | Filing History |
| 2024-02-14 09:23 am Purchase | 2023-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS | AVORO CAPITAL ADVISORS LLC | 13,411,111 9.900% | 2,786,111 (+26.22%) | Filing History |
| 2024-02-14 09:22 am Purchase | 2023-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | AVORO CAPITAL ADVISORS LLC | 27,400,000 9.300% | 600,000 (+2.24%) | Filing History |
| 2024-02-14 09:21 am Purchase | 2023-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL | AVORO CAPITAL ADVISORS LLC | 2,288,888 9.900% | 628,888 (+37.88%) | Filing History |